Patient Selection
Patients who underwent a catheter ablation for PSVT from January 1, 2010
to December 31, 2020 were examined. Psychiatric medications that were
prescribed to the patient prior to ablation were recorded. Symptoms of
PSVT were also noted. Patients that were not on any psychiatric
medications and patients with unsuccessful ablation were excluded. Of
the included patients, the number of psychiatric medications at 3 months
post-ablation were noted. Baseline characteristics including age,
ethnicity, gender, and cardiovascular medications were recorded.